In this study, LAIR-1 on AML cells led to downstream signaling through Ca++/calmodulin-dependent protein kinase I (CAMK1) and cAMP response element–binding protein (CREB), which was implicated in sustaining AML stem cell activity. The gene discussed is CREB1; the disease is acute myeloid leukemia.